Modeling restoration of gefitinib efficacy by co‐administration of MET inhibitors in an EGFR inhibitor‐resistant NSCLC xenograft model: A tumor‐in‐host DEB‐based approach

por Elena M. Tosca, Glenn Gauderat, Sylvain Fouliard, Mike Burbridge, Marylore Chenel, Paolo Magni
Publicado 2021

dCas9 regulator to neutralize competition in CRISPRi circuits

por Hsin-Ho Huang, Massimo Bellato, Yili Qian, Pablo Cárdenas, Lorenzo Pasotti, Paolo Magni, Domitilla Del Vecchio
Publicado 2021

High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation

por Massimiliano Ruscica, Margherita Botta, Nicola Ferri, Eleonora Giorgio, Chiara Macchi, Guido Franceschini, Paolo Magni, Laura Calabresi, Monica Gomaraschi
Publicado 2018

Integrative Analysis of Multi-Omics and Genetic Approaches—A New Level in Atherosclerotic Cardiovascular Risk Prediction

por EIena I. Usova, Asiiat S. Alieva, Alexey N. Yakovlev, Madina S. Alieva, Alexey A. Prokhorikhin, Alexandra O. Konradi, Evgeny V. Shlyakhto, Paolo Magni, Alberico L. Catapano, Andrea Baragetti
Publicado 2021